Anti-IL-6 receptor antibody for the treatment of juvenile idiopathic arthritis

摘要

The present invention provides compositions and methods for treating and ameliorating the symptoms of systemic juvenile idiopathic arthritis and polyarticular-process juvenile idiopathic arthritis using an antibody that specifically binds to human interleukin-6 receptor (HL-6R).